Advertisement

Thromboembolic Risk in Patients with Atrial Fibrillation: Can It Be Predicted on the Basis of Clinical Variables?

  • S. Scardi
  • C. Mazzone
  • D. Goldstein
  • C. Pandullo
  • G. Sinagra
Conference paper

Abstract

Atrial fibrillation (AF) is a common disorder of cardiac rhythm and its incidence increases with each decade of life (1). In the past, rheumatic mitral valve disease has been the condition most highly associated with AF. However, more recently, other conditions have assumed greater importance, particularly AF which is not associated with rheumatic valvular heart disease (NRAF). The risk of stroke in these patients is estimated to be fivefold greater than that of comparable patients in sinus rhythm (2).

Keywords

Atrial Fibrillation Embolic Event Left Atrial Appendage Mitral Annular Calcification Left Atrial Appendage Thrombus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wolf PA, Dawber TR, Thomas HE et al (1978) Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 28: 973–977PubMedGoogle Scholar
  2. 2.
    Chesebro JH, Fuster V, Halperin JL (1990) Atrial fibrillation, risk marker for stroke. N Engl J Med 323: 1556–1558PubMedCrossRefGoogle Scholar
  3. 3.
    Flegel KM, Shipley MJ, Rose G (1987) Risk of stroke in non-rheumatic atrial fibrillation. Lancet l: 526–529PubMedCrossRefGoogle Scholar
  4. 4.
    Scardi S (1993) La profilassi tromboembolica nella fibrillazione atriale non reumatica: quando e come farla? Prim Cardiol 8: 113–121Google Scholar
  5. 5.
    Connoly SJ, Laupacis A, Gent M et al (1991) Canadian Atrial Fibrillation Anticoagulation ( CAFA) study. J Am Coll Cardiol 18: 349–355CrossRefGoogle Scholar
  6. 6.
    Petersen P, Boysen G, Godtfredsen J et al (1989) Placebo-controlled, randomised trial, of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet 1: 175–177PubMedCrossRefGoogle Scholar
  7. 7.
    The Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke Prevention in Atrial Fibrillation study. Circulation 84: 527–539Google Scholar
  8. 8.
    The Boston Area Anticoagulation Trial in Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323: 1505–1511CrossRefGoogle Scholar
  9. 9.
    Benjamin EJ, Plehn JF, D’Agostino RB et al (1992) Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med 327: 374–379PubMedCrossRefGoogle Scholar
  10. 10.
    Wolf PA, Kannel WB, Mc Gee DL et al (1983) Duration of atrial fibrillation and imminence of stroke: the Framingham Study. Stroke 14 (5): 664–667PubMedCrossRefGoogle Scholar
  11. 11.
    Petersen P, Kastrup J, Brinch K et al (1987) Relation between left atrial dimension and duration of atrial fibrillation. Am J Cardiol 60: 382–384PubMedCrossRefGoogle Scholar
  12. 12.
    Andersen JS, Egelblad H, Abilgaarg J et al (1991) Atrial fibrillation and left atrial enlargement: cause or effect? J Intern Med 229: 253–256PubMedCrossRefGoogle Scholar
  13. 13.
    Pearson AC, Labowitz AJ, Tatineni S et al (1991) Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 17: 66–72PubMedCrossRefGoogle Scholar
  14. 14.
    Black W, Hopkins AP, Lee LCL et al (1991) Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol 18: 398–404PubMedCrossRefGoogle Scholar
  15. 15.
    Verhorst PMJ, Kamp O, Visser CA et al (1993) Left atrial appendage flow velocity assessment using transesophageal echocardiography in nonrheumatic atrial fibrillation and systemic embolism. Am J Cardiol 71: 192–196PubMedCrossRefGoogle Scholar
  16. 16.
    Suetsugu M, Matsuzaki M, Toma Y (1988) Detection of mural thrombi and analysis of blood flow velocities in the left atrial appendage using transesophageal two-dimensional echocardiography and pulsed Doppler flowmetry. J Cardiol 18: 385–394PubMedGoogle Scholar
  17. 17.
    Aschenberg W, Schluter M, Kremer P et al (1986) Trans-esophageal two dimensional echocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol 7: 163–166PubMedCrossRefGoogle Scholar
  18. 18.
    Mugge A, Daniel WG, Hausmann D et al (1990) Diagnosis of left atrial appendage thrombi by transesophageal echocardiography: clinical implication and follow up. Am J Cardiac Imaging 4: 173–179Google Scholar
  19. 19.
    Yamamoto K, Ikeda U, Seino Y et al (1995) Coagulation activity is increased in the left atrium of patients with mitral stenosis. J Am Coll Cardiol 25: 107–112PubMedCrossRefGoogle Scholar
  20. 20.
    Asakura H, Hifumi S, Jokaji H et al (1992) Prothrombin fragment F1+2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable sate in atrial fibrillation. Blood Coagulation Fibrinolysis 3: 469–473PubMedGoogle Scholar
  21. 21.
    Rylatt DB, Blake AS, Cottis IE et al (1983) An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 31: 767–778PubMedCrossRefGoogle Scholar
  22. 22.
    The Stroke Prevention in Atrial Fibrillation Investigators (1994) Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study. Lancet 343: 687–691Google Scholar

Copyright information

© Springer-Verlag Italia, Milano 1996

Authors and Affiliations

  • S. Scardi
    • 1
  • C. Mazzone
    • 1
  • D. Goldstein
    • 1
  • C. Pandullo
    • 1
  • G. Sinagra
    • 1
  1. 1.Centro CardiovascolareOspedale MaggioreTriesteItaly

Personalised recommendations